BACKGROUND: To examine whether lifetime DSM-IV diagnosis of major depressive disorder (MDD), including age at onset and number of episodes, is associated with brain atrophy in older persons without dementia. METHOD: Within the population-based Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study, 4354 persons (mean age 76 ± 5 years, 58% women) without dementia had a 1.5-T brain magnetic resonance imaging (MRI) scan. Automated brain segmentation total and regional brain volumes were calculated. History of MDD, including age at onset and number of episodes, and MDD in the past 2 weeks was diagnosed according to DSM-IV criteria using the Mini-International Neuropsychiatric Interview (MINI). RESULTS: Of the total sample, 4.5% reported a lifetime history of MDD; 1.5% had a current diagnosis of MDD (including 75% with a prior history of depression) and 3.0% had a past but no current diagnosis (remission). After adjusting for multiple covariates, compared to participants never depressed, those with current MDD (irrespective of past) had more global brain atrophy [B = -1.25%, 95% confidence interval (CI) -2.05 to -0.44], including more gray- and white-matter atrophy in most lobes, and also more atrophy of the hippocampus and thalamus. Participants with current, first-onset MDD also had more brain atrophy (B = -1.62%, 95% CI -3.30 to 0.05) whereas those remitted did not (B = 0.06%, 95% CI -0.54 to 0.66). CONCLUSIONS: In older persons without dementia, current MDD, irrespective of prior history, but not remitted MDD was associated with widespread gray- and white-matter brain atrophy. Prospective studies should examine whether MDD is a consequence of, or contributes to, brain volume loss and development of dementia.
BACKGROUND: To examine whether lifetime DSM-IV diagnosis of major depressive disorder (MDD), including age at onset and number of episodes, is associated with brain atrophy in older persons without dementia. METHOD: Within the population-based Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study, 4354 persons (mean age 76 ± 5 years, 58% women) without dementia had a 1.5-T brain magnetic resonance imaging (MRI) scan. Automated brain segmentation total and regional brain volumes were calculated. History of MDD, including age at onset and number of episodes, and MDD in the past 2 weeks was diagnosed according to DSM-IV criteria using the Mini-International Neuropsychiatric Interview (MINI). RESULTS: Of the total sample, 4.5% reported a lifetime history of MDD; 1.5% had a current diagnosis of MDD (including 75% with a prior history of depression) and 3.0% had a past but no current diagnosis (remission). After adjusting for multiple covariates, compared to participants never depressed, those with current MDD (irrespective of past) had more global brain atrophy [B = -1.25%, 95% confidence interval (CI) -2.05 to -0.44], including more gray- and white-matter atrophy in most lobes, and also more atrophy of the hippocampus and thalamus. Participants with current, first-onset MDD also had more brain atrophy (B = -1.62%, 95% CI -3.30 to 0.05) whereas those remitted did not (B = 0.06%, 95% CI -0.54 to 0.66). CONCLUSIONS: In older persons without dementia, current MDD, irrespective of prior history, but not remitted MDD was associated with widespread gray- and white-matter brain atrophy. Prospective studies should examine whether MDD is a consequence of, or contributes to, brain volume loss and development of dementia.
Authors: Mirjam I Geerlings; Adam M Brickman; Nicole Schupf; Davangere P Devanand; José A Luchsinger; Richard Mayeux; Scott A Small Journal: J Alzheimers Dis Date: 2012 Impact factor: 4.472
Authors: P Cédric M P Koolschijn; Neeltje E M van Haren; Gerty J L M Lensvelt-Mulders; Hilleke E Hulshoff Pol; René S Kahn Journal: Hum Brain Mapp Date: 2009-11 Impact factor: 5.038
Authors: Jakub Z Konarski; Roger S McIntyre; Sidney H Kennedy; Shahryar Rafi-Tari; Joanna K Soczynska; Terence A Ketter Journal: Bipolar Disord Date: 2008-02 Impact factor: 6.744
Authors: Bruno R Barros; Alexander Schacht; Michael Happich; Foula Televantou; Lovisa Berggren; Daniel J Walker; Hector J Dueñas Journal: Prim Care Companion CNS Disord Date: 2014-10-02
Authors: Larus S Gudmundsson; Ann I Scher; Sigurdur Sigurdsson; Mirjam I Geerlings; Jean-Sebastien Vidal; Gudny Eiriksdottir; Melissa I Garcia; Tamara B Harris; Olafur Kjartansson; Thor Aspelund; Mark A van Buchem; Vilmundur Gudnason; Lenore J Launer Journal: Neurology Date: 2013-05-22 Impact factor: 9.910
Authors: Warren D Taylor; Yi Deng; Brian D Boyd; Manus J Donahue; Kimberly Albert; Maureen McHugo; Jason A Gandelman; Bennett A Landman Journal: Brain Imaging Behav Date: 2020-02 Impact factor: 3.978
Authors: Milan Chang; Jon Snaedal; Bjorn Einarsson; Sigurbjorn Bjornsson; Jane S Saczynski; Thor Aspelund; Melissa Garcia; Vilmundur Gudnason; Tamara B Harris; Lenore J Launer; Palmi V Jonsson Journal: J Gerontol A Biol Sci Med Sci Date: 2015-11-02 Impact factor: 6.053
Authors: Warren D Taylor; Douglas R McQuoid; Martha E Payne; Anthony S Zannas; James R MacFall; David C Steffens Journal: Am J Geriatr Psychiatry Date: 2013-11-22 Impact factor: 4.105
Authors: C M Imai; T I Halldorsson; T Aspelund; G Eiriksdottir; L J Launer; I Thorsdottir; T B Harris; V Gudnason; I A Brouwer; I Gunnarsdottir Journal: J Nutr Health Aging Date: 2018 Impact factor: 5.285